P
Philip N. Hawkins
Researcher at University College London
Publications - 420
Citations - 16860
Philip N. Hawkins is an academic researcher from University College London. The author has contributed to research in topics: Amyloidosis & AL amyloidosis. The author has an hindex of 66, co-authored 420 publications receiving 13773 citations. Previous affiliations of Philip N. Hawkins include Royal Free Hospital.
Papers
More filters
Journal ArticleDOI
Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): A consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis
Morie A. Gertz,Raymond L. Comenzo,Rodney H. Falk,Jean Paul Fermand,Bouke P. C. Hazenberg,Philip N. Hawkins,Giampaolo Merlini,Philippe Moreau,Pierre Ronco,Vaishali Sanchorawala,Orhan Sezer,Alan Solomon,Giles Grateau +12 more
TL;DR: A consensus panel was convened comprising 13 specialists actively involved in the treatment of patients with amyloidosis, and a consensus was developed defining each organ involved and the criteria for response.
Journal ArticleDOI
Noncontrast T1 mapping for the diagnosis of cardiac amyloidosis.
Theodoros D. Karamitsos,Stefan K. Piechnik,Sanjay M Banypersad,Marianna Fontana,Ntobeko A.B. Ntusi,Vanessa M Ferreira,Vanessa M Ferreira,Carol J. Whelan,Saul G. Myerson,Matthew D. Robson,Philip N. Hawkins,Stefan Neubauer,James C. Moon +12 more
TL;DR: Noncontrast T1 mapping has high diagnostic accuracy for detecting cardiac AL amyloidosis, correlates well with markers of systolic and diastolic dysfunction, and is potentially more sensitive for detecting early disease than LGE imaging.
Journal ArticleDOI
Clinical and subclinical inflammation in patients with familial Mediterranean fever and in heterozygous carriers of MEFV mutations
Helen J. Lachmann,Bulent Sengul,Tugba Yavuzsen,David R. Booth,SE Booth,A Bybee,J. R. Gallimore,Müjde Soytürk,Servet Akar,Mehmet Tunca,Philip N. Hawkins +10 more
TL;DR: Substantial sub-clinical inflammation occurs widely and over prolonged periods in patients with FMF, indicating that the relatively infrequent clinically overt attacks represent the 'tip of the iceberg' in this disorder.
Journal ArticleDOI
In vivo regulation of interleukin 1β in patients with cryopyrin-associated periodic syndromes
Helen J. Lachmann,Philip J. Lowe,SD Felix,Christiane Rordorf,Kieron S. Leslie,S Madhoo,Helmut Wittkowski,Stephan Bek,Nicole Hartmann,Sophie Bosset,Philip N. Hawkins,Thomas Jung +11 more
TL;DR: It is demonstrated that by administering the anti–human IL-1β antibody canakinumab to humans, the resulting formation of IL–1β–antibody complexes allowed the detection of in vivo–produced IL- 1β, and indicated that CAPS is entirely mediated by IL-2β and that canakinUMab treatment restores physiological IL-3β production.
Journal ArticleDOI
Cardiovascular magnetic resonance measurement of myocardial extracellular volume in health and disease
Daniel Sado,Andrew S. Flett,Sanjay M Banypersad,Steven K White,Viviana Maestrini,Giovanni Quarta,Robin H. Lachmann,Elaine Murphy,Atul Mehta,Derralynn Hughes,William J. McKenna,Andrew M. Taylor,Andrew M. Taylor,Derek J. Hausenloy,Philip N. Hawkins,Perry M. Elliott,James C. Moon +16 more
TL;DR: Myocardial ECV, assessed non-invasively in the septum with equilibrium contrast cardiovascular magnetic resonance, shows gender differences in normal individuals and disease-specific variability, and shows early potential to be a useful biomarker in health and disease.